MRI as Noninvasive Innovative Approach in Detection and Monitoring of Malignant Oral Lesions in Fanconi Anemia Patients

ConditionFanconi Anemia

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexAll

Age18+

SponsorUniversity of Minnesota

About this trial

This study being done to learn more about the use of medical Magnetic Resonance Imaging (mMRI) and dedicated dental MRI (ddMRI) as a non-invasive diagnosing tool when evaluating potential oral cancerous and precancerous lesions in Fanconi Anemia patients.

Eligibility criteria

Qualifiers

Patients with a diagnosis of Fanconi Anemia who are willing to participate and willing to have MRIs

Willing to provide informed consent

Disqualifiers

Patient without diagnosis of FA

Patients with FA who are under the age of 18

Unable to tolerate any MRI due to claustrophobia

Any contraindication for the MRI

Trial design

Treatments tested in this trial

MRIs

Treatment groups

80 Participants

are divided into 2 treatment groups

Sponsors and collaborators

University of Minnesota

Lead sponsor

Source ClinicalTrials.gov